Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Oncopeptides Major Shareholding Notification 2024

Jun 13, 2024

3091_iss_2024-06-13_c3d92464-67ff-43ed-87c6-ddc3d5165e80.pdf

Major Shareholding Notification

Open in viewer

Opens in your device viewer

Issuer Oncopeptides AB

Holder

Nordnet AB (publ)

Instrument

Instrument Aktie SE0009414576
Before the transaction
Shares Data not given*
Voting rights Data not given*
Transaction
Reason for major shareholding notification Share loan
Date 11/06/2024
Limit for number of votes 5 %
After the transaction
Quantity
Shares 10,486,684
Directly held voting rights 0
Indirectly held voting rights 10,486,684
Percentage
Directly held shares 4.8733 %
Directly held voting rights 0 %
Indirectly held voting rights 4.9596 %

Resulting distribution of total holdings

Percentage of voting
rights:
Number of underlying
shares:
Shares 4.9596 % 10,486,684
paragraph, line 2
Instruments - FITA Ch. 4, section 2,
first paragraph, line 3
Instruments - FITA Ch. 4, section 2, first
- Physically settled
- Cash settled
Total 4.9596 % 10,486,684
Chain
of
controlling
companies
Voting rights % Voting rights Company
10,179,989 4.81455
306,695
0.14504
Nordnet Pensionsförsäkring AB
Nordnet Livsforsikring AS
total
Group
holdings
Voting rights 10,486,684
Percentage of voting rights 4.9596
Published
13/06/2024 13:59
Contact
Name
Felix Mandoki
Phone +46766110734 Email [email protected]

*Source of information has chosen not to submit the data

CLOSE PRINT

[email protected] Tfn 08-408 980 37 Fax 08-24 39 25